PharmacovigilanceOfficial
AIFA closes monitoring registries for ZYDELIG (AIFA)
🇮🇹 AIFA · Thu 22 Oct 2026
AIFA has announced that, effective 22/10/2026, monitoring will end for the ZYDELIG (idelalisib) AIFA Monitoring Registry for specific therapeutic indications, meaning prescribers in Italy will no longer need to use this registry for those indications.
Summary written by VigiEye from the official notice. AI-assisted; check the source before acting.
More Pharmacovigilance
All →
PharmacovigilanceOfficialMedline details repair and replace programme for recalled beds, rails, mattresses and accessories
🇺🇸 FDA MedWatch · Fri 13 Nov 2026
PharmacovigilanceOfficialPRAC publishes final EU-language translations of phenobarbital product information in targeted signal procedure
🇪🇺 EMA · PRAC · Fri 13 Nov 2026
PharmacovigilanceOfficialEMA page on veterinary signal management details phenobarbital review and updated MAH templates
🇪🇺 EMA · PRAC · Fri 13 Nov 2026
PharmacovigilanceOfficialEMA publishes draft veterinary PV guideline listing medically important VeDDRA terms
🇪🇺 EMA · Fri 13 Nov 2026
PharmacovigilanceOfficialEMA opens consultation on medically important VeDDRA terms list for veterinary pharmacovigilance
🇪🇺 EMA · Fri 13 Nov 2026
PharmacovigilanceOfficialFTC sues to block Covetrus's $3.5bn acquisition of veterinary distributor MWI
🇺🇸 FTC · Fri 13 Nov 2026